Notice of Application - 2012
[Federal Register Volume 77, Number 152 (Tuesday, August 7, 2012)]
[Notices]
[Page 47115]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-19194]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Application;
Cayman Chemical Company
Pursuant to Sec. 1301.33(a), Title 21 of the Code of Federal
Regulations (CFR), this is notice that on June 1, 2012, Cayman Chemical
Company, 1180 East Ellsworth Road, Ann Arbor, Michigan 48108, made
application by renewal to the Drug Enforcement Administration (DEA) to
be registered as a bulk manufacturer of the following basic classes of
controlled substances:
| Drug |
Schedule |
| Cathinone (1235) |
I |
| Methcathinone (1237) |
I |
| 4-Methyl-N-methylcathinone (1248) |
I |
| N-Ethylamphetamine (1475) |
I |
| N,N-Dimethylamphetamine (1480) |
I |
| Aminorex (1585) |
I |
| 4-Methylaminorex (cis isomer) (1590) |
I |
| Gamma Hydroxybutyric Acid (2010) |
I |
| 1-Pentyl-3-(1-naphthoyl)indole (7118) |
I |
| 1-Butyl-3-(1-naphthoyl)indole (7173) |
I |
| 1-[2-(4-Morpholinyl)ethyl]-3-(1-naphthoyl) indole (7200) |
I |
| Alpha-ethyltryptamine (7249) |
I |
| 5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol (7297) |
I |
| 5-(1,1-Dimethyloctyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol (7298) |
I |
| Lysergic acid diethylamide (7315) |
I |
| 2,5-Dimethoxy-4-(n)-propylthiophenethylamine (7348) |
I |
| Marihuana (7360) |
I |
| Tetrahydrocannabinols (7370) |
I |
| Mescaline (7381) |
I |
| 3,4,5-Trimethoxyamphetamine (7390) |
I |
| 4-Bromo-2,5-dimethoxyamphetamine (7391) |
I |
| 4-Bromo-2,5-dimethoxyphenethylamine (7392) |
I |
| 4-Methyl-2,5-dimethoxyamphetamine (7395) |
I |
| 2,5-Dimethoxyamphetamine (7396) |
I |
| 2,5-Dimethoxy-4-ethylamphetamine (7399) |
I |
| 3,4-Methylenedioxyamphetamine (7400) |
I |
| 5-Methoxy-3,4-methylenedioxyamphetamine (7401) |
I |
| N-Hydroxy-3,4-methylenedioxyamphetamine (7402) |
I |
| 3,4-Methylenedioxy-N-ethylamphetamine (7404) |
I |
| 3,4-Methylenedioxymethamphetamine (7405) |
I |
| 4-Methoxyamphetamine (7411) |
I |
| 5-Methoxy-N-N-dimethyltryptamine (7431) |
I |
| Alpha-methyltryptamine (7432) |
I |
| Bufotenine (7433) |
I |
| Diethyltryptamine (7434) |
I |
| Dimethyltryptamine (7435) |
I |
| Psilocybin (7437) |
I |
| Psilocyn (7438) |
I |
| 5-Methoxy-N,N-diisopropyltryptamine (7439) |
I |
| N-Benzylpiperazine (7493) |
I |
| 3,4-Methylenedioxypyrovalerone (7535) |
I |
| 3,4-Methylenedioxy-N-methylcathinone (7540) |
I |
| Amphetamine (1100) |
II |
| Methamphetamine (1105) |
II |
| Lisdexamfetamine (1205) |
II |
The company plans to manufacture small quantities of marihuana
derivatives for research purposes. In reference to drug code 7360
(Marihuana), the company plans to bulk manufacture cannabidiol. In
reference to drug code 7370 (Tetrahydrocannabinols), the company will
manufacture a synthetic THC. No other activity for this drug code is
authorized for this registration.
The company plans to manufacture the remaining listed controlled
substances to supply these materials to the research and forensics
community for drug testing and analysis.
Any other such applicant, and any person who is presently
registered with DEA to manufacture such substances, may file comments
or objections to the issuance of the proposed registration pursuant to
21 CFR Sec. 1301.33(a).
Any such written comments or objections should be addressed, in
quintuplicate, to the Drug Enforcement Administration, Office of
Diversion Control, Federal Register Representative (ODL), 8701
Morrissette Drive, Springfield, Virginia 22152; and must be filed no
later than October 9, 2012.
Dated: July 30, 2012.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 2012-19194 Filed 8-6-12; 8:45 am]
BILLING CODE 4410-09-P
NOTICE: This is an unofficial version. An official version of this publication may be obtained
directly from the Government Printing Office (GPO). |
